归创通桥医疗科技股份有限公司（02190）于2026年3月18日刊发翌日披露报表，披露当日于香港联交所场内回购股份10万股，占该次回购前已发行股份（不包括库藏股）总数的约0.0296%。
本次回购的每股价格介乎港币21.26元至22.18元，总金额约218.24万港元。回购完成后，公司已发行股份（不包括库藏股）为329,404,613股，库藏股数增至6,946,131股。
公告显示，此次回购依据2025年5月30日通过的回购授权进行。截至目前，公司可回购股份数量为31,958,111股，已回购股份累计4,126,500股，占授权时已发行股份总数约1.2608%。公司确认已遵守香港联交所的上市规则及相关法规。
本公告由公司董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.